FDA
approval
· 2015-03-23
FDA Approved: EPIVIR — Supplemental Application (ViiV Healthcare Company)
Summary
The FDA approved a supplemental application for EPIVIR (lamivudine) submitted by ViiV Healthcare Company, indicating changes to its labeling as part of the appr…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for EPIVIR (LAMIVUDINE)